Journal article · 2020 · Open access

Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States

Saima Aslam, Elizabeth Lampley, Darcy A Wooten, Maile Karris, Constance Ann Benson, Steffanie A. Strathdee, Robert Turner Schooley

Open Forum Infectious Diseases, 7(9), ofaa389 · Published 27 August 2020 · DOI 10.1093/ofid/ofaa389

Free PDFView at the publisherCite this paper

In brief

“Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States” is a 2020 journal article by Saima Aslam and 6 co-authors, published in Open Forum Infectious Diseases. OpenAlex counts 370 citations as of 15 November 2026, which puts it in the top 7% of works published in 2020 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Open Forum Infectious Diseases.

Citations
370
Most cited in
2026 (71)
Field-weighted impact
17.16
References
14
Authors
7

Abstract

BACKGROUND: Due to increasing multidrug-resistant (MDR) infections, there is an interest in assessing the use of bacteriophage therapy (BT) as an antibiotic alternative. After the first successful case of intravenous BT to treat a systemic MDR infection at our institution in 2017, the Center for Innovative Phage Applications and Therapeutics (IPATH) was created at the University of California, San Diego, in June 2018. METHODS: We reviewed IPATH consult requests from June 1, 2018, to April 30, 2020, and reviewed the regulatory process of initiating BT on a compassionate basis in the United States. We also reviewed outcomes of the first 10 cases at our center treated with intravenous BT (from April 1, 2017, onwards). RESULTS: . Intravenous BT was safe with a successful outcome in 7/10 antibiotic-recalcitrant infections at our center (6 were before IPATH). BT may be safely self-administered by outpatients, used for infection suppression/prophylaxis, and combined successfully with antibiotics despite antibiotic resistance, and phage resistance may be overcome with new phage(s). Failure occurred in 2 cases despite in vitro phage susceptibility. CONCLUSIONS: We demonstrate the safety and feasibility of intravenous BT for a variety of infections and discuss practical considerations that will be critical for informing future clinical trials.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Aslam, S., Lampley, E., Wooten, D. A., Karris, M., Benson, C. A., Strathdee, S. A., & Schooley, R. T. (2020). Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infectious Diseases, 7(9), ofaa389. https://doi.org/10.1093/ofid/ofaa389

MLA 9

Aslam, Saima, et al. “Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.” Open Forum Infectious Diseases, vol. 7, no. 9, 2020, p. ofaa389. https://doi.org/10.1093/ofid/ofaa389.

Chicago

Aslam, Saima, Elizabeth Lampley, Darcy A Wooten, Maile Karris, Constance Ann Benson, Steffanie A. Strathdee, and Robert Turner Schooley. 2020. “Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.” Open Forum Infectious Diseases 7 (9): ofaa389. https://doi.org/10.1093/ofid/ofaa389.

Harvard

Aslam, S. et al. (2020) ‘Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States’, Open Forum Infectious Diseases, 7(9), p. ofaa389. doi:10.1093/ofid/ofaa389.

IEEE

S. Aslam et al., “Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States,” Open Forum Infectious Diseases, vol. 7, no. 9, p. ofaa389, 2020, doi: 10.1093/ofid/ofaa389.

BibTeX

@article{aslam2020lessons,
  title     = {{Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States}},
  author    = {Aslam, Saima and Lampley, Elizabeth and Wooten, Darcy A and Karris, Maile and Benson, Constance Ann and Strathdee, Steffanie A. and Schooley, Robert Turner},
  journal   = {Open Forum Infectious Diseases},
  year      = {2020},
  volume    = {7},
  number    = {9},
  pages     = {ofaa389},
  doi       = {10.1093/ofid/ofaa389},
  url       = {https://doi.org/10.1093/ofid/ofaa389}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202022
20216868
20225151
20235757
20246161
20255959
20267171

Its field-weighted citation impact is 17.16: it has been cited 17.16 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions

  • phage therapy
  • multidrug-resistant bacterial infections
  • antibiotic resistance
  • phage therapy safety
  • phage resistance
  • infection control
  • systemic infection

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Aslam, S., Lampley, E., Wooten, D. A., Karris, M., Benson, C. A., Strathdee, S. A., & Schooley, R. T. (2020). Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infectious Diseases, 7(9), ofaa389. https://doi.org/10.1093/ofid/ofaa389

How many times has this paper been cited?

370 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Open Forum Infectious Diseases.

Who wrote this paper?

Saima Aslam, Elizabeth Lampley, Darcy A Wooten, Maile Karris, Constance Ann Benson, Steffanie A. Strathdee, Robert Turner Schooley.

What is the DOI of this paper?

10.1093/ofid/ofaa389. The permanent link is https://doi.org/10.1093/ofid/ofaa389.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.